BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11384665)

  • 1. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
    Stanilova SA; Slavov ES
    J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New ELISA kits using C3 binding glycoprotein from Cuscuta europea detect mainly IgM CIC in rheumatoid arthritis and progressive systemic sclerosis, but not in systemic lupus erythematosus.
    Stanilova SA; Slavov ES
    Clin Dev Immunol; 2003; 10(2-4):111-7. PubMed ID: 14768941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined IGG, IGM and IGA peroxidase conjugate can facilitate determination of immune complexes by CIF-ELISA and anti-C3 ELISA.
    Slavov E
    Folia Med (Plovdiv); 1999; 41(1):149-52. PubMed ID: 10462947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved anti-C3/IgG ELISA for quantification of soluble immune complexes.
    Soares NM; Santiago MB; Pontes deCarvalho LC
    J Immunol Methods; 2001 Mar; 249(1-2):199-205. PubMed ID: 11226477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
    Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
    Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA.
    Yoshinoya S; Mizoguchi Y; Aotsuka S; Yokohari R; Nishioka K; Miyamoto T
    J Clin Lab Immunol; 1992; 38(4):161-73. PubMed ID: 11270517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tests for circulating immune complexes.
    Wener MH
    Methods Mol Biol; 2014; 1134():47-57. PubMed ID: 24497353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating immune complexes with polyethylene glycol precipitation F(ab')2 anti-C3 ELISA.
    Xu RJ; Gu YA
    J Immunol Methods; 1990 Dec; 135(1-2):225-31. PubMed ID: 2273258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A C1Q enzyme-linked immunosorbent assay (ELISA) using polyethylene glycol for immune complexes.
    Lunde MN
    Am J Trop Med Hyg; 1983 Mar; 32(2):392-6. PubMed ID: 6340543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P; Michaelsen TE; Aase A; Mollnes TE
    J Immunol; 1990 Jan; 144(1):198-203. PubMed ID: 2295791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bell's palsy: an immune complex disease.
    Larsson A; Jonsson L; Sjöquist J
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(3):164-7. PubMed ID: 2141682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A solid-phase anti-C3 assay for detection of immune complexes in six distinguished forms.
    Iida K; Mitomo K; Fujita T; Tamura N
    J Immunol Methods; 1987 Apr; 98(1):23-8. PubMed ID: 2435809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.